MACULAR EDEMA TREATMENT MARKET ANALYSIS

Macular Edema Treatment Market, by Disease Type (Diabetic Macular Edema and Cystoid Macular Edema), by Drug Class (Anti-Vascular Endothelial Growth Factor (VEGF) Injections (Avastin, Eylea ,and Lucentis) and Anti-inflammatory Medication (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Corticosteroid Implants (Ozurdex, Retisert, and Iluvien)), by End User (Hospitals, Ophthalmic Clinics, and Research Institutes), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI2494
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key players operating in the macular edema treatment market include, Novartis International AG, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., Pfizer Inc. Bayer AG, Aerpio Therapeutics, Inc., Biomar Microbial Technologies, Antisense Therapeutics Limited, Coherus BioSciences, and Bausch & Lomb Incorporated.